Showing results (431-440 of 466) with videos related to
Sort By:
Pageof 47
Blood|August 25, 2001
Rituximab therapy of patients with B-cell chronic lymphocytic leukemiaD Huhn, C von Schilling, M Wilhelm, et al.International Journal of Cancer|December 19, 2013
Regorafenib (BAY 73-4506): antitumor and antimetastatic activities in preclinical models of colorectal cancerRoberta Schmieder, Jens Hoffmann, Michael Becker, et al.Oncology Reports|May 9, 1998
Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological resultsH P Vollmers, U Zimmermann, V Krenn, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 4, 2013
Associations of fatty liver disease and other factors affecting serum SHBG concentrations: a population based study on 1657 subjectsM Flechtner-Mors, A Schick, S Oeztuerk, et al.The Journal of Biological Chemistry|May 15, 1988
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagenI E Collier, S M Wilhelm, A Z Eisen, et al.Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active siteE Vieira, A Binggeli, V Breu, et al.Pediatric Cardiology|October 10, 2013
Predictors of prolonged length of intensive care unit stay after stage I palliation: a report from the National Pediatric Cardiology Quality Improvement CollaborativeCarissa M Baker-Smith, Carolyn M Wilhelm, Steven R Neish, et al.Leukemia & Lymphoma|February 1, 1997
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphomaA Engert, R Schnell, F Küpper, et al.Pharmacotherapy|March 31, 2012
Importance of direct patient care in advanced pharmacy practice experiences, R Chris Rathbun, E Kelly Hester, et al.Anti-Cancer Drugs|March 10, 1998
Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancerC M Kurbacher, I A Cree, H W Bruckner, et al.Pageof 47